Plus, we’ll share some tips for staying abreast of the rapid changes so you can quickly adapt and keep trials running because we all know patients can’t afford to wait.
October 07, 2020
The regulatory landscape has shifted in the wake of COVID-19. Regulatory bodies have made concessions and released guidance in an effort to allow clinical trials to continue and also to get COVID studies up and running in record time. At the same time, the European Union (EU) has issued major judgments on Privacy and HIPAA that will also affect the industry long-term.
In this webinar, we will take a deep dive into how the regulatory changes made as a result of COVID-19 have and will continue to impact data management of clinical trials across the globe. We’ll also discuss what the future holds with regard to the recent EU rulings. Plus, we’ll share some tips for staying abreast of the rapid changes so you can quickly adapt and keep trials running because we all know patients can’t afford to wait.
Join Simone Knab, Clinical Data Architect, SK Data Consulting Pty, Ltd. in a live webinar on Tuesday, October 20, 2020 at 10am EDT (3pm BST/UK).
For more information or to register for this event, visit How Will a Second Wave of COVID-19 Impact the Regulatory Landscape?
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
Share article on social media or email: